ReviewCurrent pharmaceutical design2024

Therapeutic Potential of Sodium-glucose Co-transporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists for Patients with Acute Coronary Syndrome: A Review of Clinical Evidence.

Paschalis Karakasis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.